NLRP3 and cardiovascular disorder: These events lead to activation of NLRP3 inflammasomes and production of IL-1β and IL-18, further accelerating aging processes by driving the development of neurodegenerative diseases, cardiovascular diseases, and systemic low-grade inflammation51, 52.